CO6280502A2 - Una composicion farmaceutica - Google Patents

Una composicion farmaceutica

Info

Publication number
CO6280502A2
CO6280502A2 CO11005099A CO11005099A CO6280502A2 CO 6280502 A2 CO6280502 A2 CO 6280502A2 CO 11005099 A CO11005099 A CO 11005099A CO 11005099 A CO11005099 A CO 11005099A CO 6280502 A2 CO6280502 A2 CO 6280502A2
Authority
CO
Colombia
Prior art keywords
pharmaceutical composition
rebamipide
present
keratoconjunctive
redispersed
Prior art date
Application number
CO11005099A
Other languages
English (en)
Inventor
Shun-Ichiro Sumida
Shinichi Ishikawa
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of CO6280502A2 publication Critical patent/CO6280502A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un objeto de la presente invención es proporcionar una composición farmacéutica que contiene rebamipida, la cual no necesita redispersarse, tiene una suficiente transparencia y exhibe pH neutro a ácido para no dañar la queratoconjuntiva de un paciente que sufre de ojo seco; la presente composición farmacéutica comprende (1) rebamipida, (2) un aminoazúcar, y (3) un agente regulador de pH, que no tiene catión inorgánico.
CO11005099A 2008-06-19 2011-01-19 Una composicion farmaceutica CO6280502A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008160084 2008-06-19

Publications (1)

Publication Number Publication Date
CO6280502A2 true CO6280502A2 (es) 2011-05-20

Family

ID=41334556

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11005099A CO6280502A2 (es) 2008-06-19 2011-01-19 Una composicion farmaceutica

Country Status (27)

Country Link
US (1) US20110124682A1 (es)
EP (1) EP2285413B1 (es)
JP (1) JP5441934B2 (es)
KR (1) KR20110027786A (es)
CN (1) CN102099056B (es)
AR (1) AR072212A1 (es)
AU (1) AU2009261101B2 (es)
BR (1) BRPI0915427A2 (es)
CA (1) CA2725487A1 (es)
CO (1) CO6280502A2 (es)
CY (1) CY1113214T1 (es)
DK (1) DK2285413T3 (es)
ES (1) ES2389583T3 (es)
HK (1) HK1149496A1 (es)
HR (1) HRP20120644T1 (es)
IL (1) IL209329A (es)
MX (1) MX2010013733A (es)
MY (1) MY150558A (es)
NZ (1) NZ589517A (es)
PL (1) PL2285413T3 (es)
PT (1) PT2285413E (es)
RU (1) RU2538694C2 (es)
SI (1) SI2285413T1 (es)
TW (1) TWI495634B (es)
UA (1) UA100164C2 (es)
WO (1) WO2009154304A2 (es)
ZA (1) ZA201008584B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201322982A (zh) * 2011-11-01 2013-06-16 Otsuka Pharma Co Ltd 用於治療前眼疾病之藥劑，該藥劑包含瑞巴派特及眼淚保持劑
TW201417814A (zh) * 2012-09-28 2014-05-16 Otsuka Pharma Co Ltd 包括瑞巴派特之醫藥組成物
KR101692578B1 (ko) 2013-04-18 2017-01-03 삼진제약주식회사 레바미피드 또는 이의 전구체를 포함하는 안구건조증의 예방 또는 치료를 위한 경구용 약제학적 조성물
WO2015034008A1 (ja) * 2013-09-05 2015-03-12 大塚製薬株式会社 レバミピドの局所止血用途
JP6854587B2 (ja) * 2015-04-17 2021-04-07 ロート製薬株式会社 医薬製剤
KR20170039347A (ko) * 2015-10-01 2017-04-11 삼진제약주식회사 레바미피드를 함유하는 신규한 점안 조성물 및 이의 제조방법
KR102307958B1 (ko) 2015-10-01 2021-10-05 삼진제약주식회사 레바미피드를 함유하는 신규한 점안 조성물 및 이의 제조방법
WO2017159585A1 (ja) * 2016-03-14 2017-09-21 参天製薬株式会社 メグルミン又はその塩からなる防腐剤
CN106491530B (zh) * 2016-12-13 2019-11-29 湖北远大天天明制药有限公司 一种眼用药物组合物
KR101840256B1 (ko) * 2017-09-21 2018-03-21 대우제약 주식회사 레바미피드를 함유하는 새로운 안구건조증 치료용 점안 조성물 및 이의 가용화 및 안정화 방법
KR101923519B1 (ko) * 2018-06-26 2019-02-27 대우제약 주식회사 레바미피드를 함유하는 안구 건조증 치료용 수용성 다회용 점안제 조성물 및 이의 가용화 및 안정화 방법
KR20200019451A (ko) 2018-08-14 2020-02-24 대우제약 주식회사 레바미피드를 함유하는 안구 건조증 치료용 수용성 다회용 점안제 조성물 및 이의 가용화 및 안정화 방법
JP6744952B2 (ja) * 2019-05-28 2020-08-19 ロート製薬株式会社 眼科用組成物
KR102615076B1 (ko) 2021-07-14 2023-12-19 대우제약 주식회사 안정한 레바미피드 점안제의 대용량 제조 방법
KR102659338B1 (ko) 2023-05-18 2024-04-19 국제약품 주식회사 안구건조증 치료용 약제학적 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR004214A1 (es) * 1995-10-12 1998-11-04 Otsuka Pharma Co Ltd Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
JP3093661B2 (ja) * 1995-10-12 2000-10-03 大塚製薬株式会社 眼疾患治療剤
KR20020050275A (ko) * 1999-11-11 2002-06-26 다케다 야쿠힌 고교 가부시키가이샤 융합 피리다진 유도체를 함유하는 점비제
TWI340650B (en) * 2004-01-21 2011-04-21 Otsuka Pharma Co Ltd Amine saly of carbostyril derivative
TWI363626B (en) * 2004-11-15 2012-05-11 Otsuka Pharma Co Ltd Aqueous ophthalmic suspension of crystalline rebamipide
TWI415629B (zh) * 2006-10-26 2013-11-21 Otsuka Pharma Co Ltd 含有瑞巴匹特之水性醫藥懸浮物及其製造方法

Also Published As

Publication number Publication date
DK2285413T3 (da) 2012-08-27
HK1149496A1 (en) 2011-10-07
CN102099056A (zh) 2011-06-15
CN102099056B (zh) 2014-10-01
NZ589517A (en) 2012-09-28
UA100164C2 (ru) 2012-11-26
WO2009154304A2 (en) 2009-12-23
SI2285413T1 (sl) 2012-09-28
AU2009261101A1 (en) 2009-12-23
WO2009154304A3 (en) 2010-12-02
TW201006800A (en) 2010-02-16
EP2285413A2 (en) 2011-02-23
PL2285413T3 (pl) 2013-01-31
JP2011524854A (ja) 2011-09-08
RU2538694C2 (ru) 2015-01-10
JP5441934B2 (ja) 2014-03-12
MX2010013733A (es) 2011-01-21
IL209329A0 (en) 2011-01-31
AR072212A1 (es) 2010-08-11
AU2009261101B2 (en) 2013-11-07
ES2389583T3 (es) 2012-10-29
HRP20120644T1 (hr) 2012-08-31
MY150558A (en) 2014-01-30
IL209329A (en) 2014-09-30
CA2725487A1 (en) 2009-12-23
BRPI0915427A2 (pt) 2015-11-03
ZA201008584B (en) 2012-01-25
EP2285413B1 (en) 2012-08-08
CY1113214T1 (el) 2016-04-13
US20110124682A1 (en) 2011-05-26
PT2285413E (pt) 2012-09-07
RU2011101713A (ru) 2012-07-27
TWI495634B (zh) 2015-08-11
KR20110027786A (ko) 2011-03-16

Similar Documents

Publication Publication Date Title
CO6280502A2 (es) Una composicion farmaceutica
MA38341A1 (fr) Modulateurs d'enzymes de modification par méthylation, compositions et utilisations associées
BR112014011860A2 (pt) soles de dióxido de titânio fotocatalítico, neutro, estável e transparente
CO7111298A2 (es) Composiciones de tratamiento de agua y métodos de uso
ECSP13012384A (es) Composición acuosa que contiene bromhexina
BR112015017405A2 (pt) composições que incluem agentes hidrofobizantes e estabilizantes e métodos para preparação e utilização das mesmas
BR112014017716A8 (pt) composições de ésteres de forbol, métodos para prevenir ou tratar acidente vascular cerebral e uso de ésteres de forbol
WO2015038939A3 (en) Modulators of complement factor b
CL2018001420A1 (es) Tratamiento de trastornos cognitivos con (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma. (divisional solicitud 201701853)
BR112014002757A2 (pt) encapsulados
BR112013014418A2 (pt) processo e fluido para o tratamento de uma formação que contém ilita
BR112015030312A2 (pt) conector óptico com material adesivo
BR112014014410A2 (pt) composições e métodos que compreendem uma variante de enzima lipolítica
BR112015027133A2 (pt) nanopartículas de fitoglicogênio e métodos de fabricação dos mesmos
BR112012024773A2 (pt) compósito de celulose, alimento e bebida contendo o mesmo, e processo para produzir um compósito de celulose
WO2011091366A3 (en) Methods of treating or preventing periodontitis and diseases associated with periodontitis
BR112015008389A2 (pt) compostos úteis na síntese de compostos de benzamida
EP2328550A4 (en) MUCOADHERENT COMPOSITIONS AND THEIR USE
BR112018007635A2 (pt) ?composição cosmética?
BR112012029009A2 (pt) formulações líquidas de fumarato de rupatadina
BR112012014572A8 (pt) sistema de fechamento para recipientes de soluções oftálmicas
BR112013019218A2 (pt) material particulado
BR112015029954A2 (pt) composição e processo para tratar as fibras queratínicas
EA201201483A1 (ru) Способы и композиции для защиты от нейротоксических веществ
BR112014026483A2 (pt) composição antimicrobiana, composição antimicrobiana bicomponente, pano de limpeza, método para desinfetar uma superfície e método para controlar esporos sobre uma superfície

Legal Events

Date Code Title Description
FC Application refused